AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. EBITDA margin (%)

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.71T
P/E ratio
18.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202512.6+9.84%
Mar 31, 202411.4-27.28%
Mar 31, 202315.7-13.42%
Mar 31, 202218.2+8.72%
Mar 31, 202116.7-30.00%
Mar 31, 202023.9+1.41%
Mar 31, 201923.5+495.55%
Mar 31, 20184

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)